国际医学:定增募资用于智慧康养及质子治疗项目

Core Viewpoint - The company is conducting a private placement of shares to raise funds for long-term strategic development, addressing investor concerns regarding potential misuse of funds and the impact on shareholder equity [1] Group 1: Fundraising Details - The total amount to be raised through the private placement is not exceeding 1,007.54 million yuan [1] - The funds will primarily be allocated to three projects: Smart Elderly Care Project, Phase II of the Proton Therapy Center, and working capital supplementation [1] Group 2: Project Allocations - The Smart Elderly Care Project has a total investment of approximately 751 million yuan, with about 638 million yuan planned to be raised, aimed at capitalizing on the "silver economy" [1] - The Phase II Proton Therapy Center project has a total investment of 99.93 million yuan, with the entire amount to be funded through the private placement, targeting the gap in the proton therapy market in Northwest China [1] - The working capital supplementation is set at 270 million yuan, intended to optimize the company's capital structure and enhance ongoing operational capabilities [1] Group 3: Strategic Intent - The private placement aligns with national policies and is a proactive choice based on the company's development strategy, aiming to seize industry growth opportunities and improve asset utilization [1] - The company emphasizes its commitment to maintaining proper operations and protecting the legal rights of all shareholders, particularly minority shareholders [1]